These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3868788)

  • 1. [Formation of platelet thromboxane in a patient with type I glycogenosis].
    Strano A; Davì G; Averna M; Benigno V; D'Alessandro G; La Grutta A; Notarbartolo A
    Recenti Prog Med; 1985 Dec; 76(12):619-22. PubMed ID: 3868788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and biochemical aspects of type I glycogenosis].
    Rossi A la R; Nacagami J; Strufaldi B; Nozaki MJ
    Rev Farm Bioquim Univ Sao Paulo; 1973; 11(2):196-208. PubMed ID: 4373797
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.
    Bandsma RH; Rake JP; Visser G; Neese RA; Hellerstein MK; van Duyvenvoorde W; Princen HM; Stellaard F; Smit GP; Kuipers F
    J Pediatr; 2002 Feb; 140(2):256-60. PubMed ID: 11865283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neutropenia and glycogenosis type IB].
    Couselo Sánchez JM; López Rivas M; Pérez Becerra E; Rodríguez Cervilla J; Pavón Belinchón P; Fraga Bermúdez JM; Peña Guitián J
    An Esp Pediatr; 1983 Jun; 18(6):505-9. PubMed ID: 6578695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unusual form of glycogenosis type 1 (Gierke's disease)].
    Chibisov IV; Rozenfel'd EL; Chistova LV; Leont'ev AF; Mantasheva VA
    Vopr Okhr Materin Det; 1978 Mar; 23(3):81-4. PubMed ID: 274013
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of bone changes in glycogenosis. II. Role of magnesium in the development of bone changes and the relationship of magnesemia to plasma lipid level].
    Halikowski B; Kucharska K; Stopyrowa J
    Pediatr Pol; 1970 Mar; 45(3):293-8. PubMed ID: 5266391
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet malondialdehyde and plasma thromboxane B2 formation in patients with obliterative arteriosclerosis of the lower limbs.
    Bodzenta A; Bielawiec M; Krupiński K; Wojtukiewicz M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):804-7. PubMed ID: 6188668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrinological findings in patients with glycogenosis.
    Bierich JR; Rager K; Schönberg D
    Acta Endocrinol Suppl (Copenh); 1973; 173():128. PubMed ID: 4542066
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
    Qu YZ; Wang YE; Li XX
    Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gout as a complication of adult glycogen storage disease].
    Neubaur J; Willms B; Söling HD; Creutzfeldt W
    Arch Klin Med; 1969; 216(2):148-60. PubMed ID: 5256428
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation, and plasma-free fatty acids in normal subjects.
    Galli C; Colli S; Gianfranceschi G; Maderna P; Petroni A; Tremoli E; Marinovich M; Sirtori CR
    Drug Nutr Interact; 1984; 3(1):61-7. PubMed ID: 6510241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease type Ib without hypoglycemia.
    Kovacevic A; Ehrlich R; Mayatepek E; Wendel U; Schwahn B
    Mol Genet Metab; 2007 Mar; 90(3):349-50. PubMed ID: 17174133
    [No Abstract]   [Full Text] [Related]  

  • 14. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.
    Best LC; Holland TK; Jones PB; Russell RG
    Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation disorders in glycogenosis, type I. Description of 2 cases].
    Pasquale M; Brisotto P; Bolesani C; Lazzarato C
    Minerva Pediatr; 1980 Aug; 32(16):973-80. PubMed ID: 6935498
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction.
    Strano A; Davi G; Traina M; Novo S; Raineri A
    Thromb Haemost; 1981 Dec; 46(4):759. PubMed ID: 7036402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatic forms of glycogenosis - clinical and biochemical findings in 15 cases].
    Pronicka E; Pieniazek D; Miłoszewska E; Gruszczyńska B; Moszczyńska A
    Pediatr Pol; 1983 May; 58(5):437-45. PubMed ID: 6579490
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro.
    Shan CW; Lin JH; Jin YH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):164-6. PubMed ID: 10374644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectively "cross-bridged" hemostatic and blood screening test defects due to glycogenosis type 1 associated extremely hyperlipidemia.
    Balint B; Todorovic-Balint M; Petakov M; Ostojic G; Vucetic D
    Transfus Apher Sci; 2014 Apr; 50(2):314-5. PubMed ID: 24556126
    [No Abstract]   [Full Text] [Related]  

  • 20. Variability of renal length in type I glycogen storage disease.
    Chen YT; Feinstein KA; Coleman RA; Effmann EL
    J Inherit Metab Dis; 1990; 13(3):259-62. PubMed ID: 2122080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.